Bioanalytical Services
Product
Information
Accurate and reliable measurement of drug concentrations and biomarkers in biological matrices is fundamental to drug development success. ResolveMass Laboratories offers GLP-compliant bioanalytical method development and validation for a broad range of analytes — spanning small molecules, large molecules, peptides, oligonucleotides, and complex biologics — across all phases of preclinical and clinical development. Our bioanalytical platform is built on LC-MS/MS, complemented by ligand-binding assay (LBA) technologies including ELISA and electrochemiluminescence (ECL), enabling us to support the full spectrum of bioanalytical needs. All studies are conducted under 21 CFR Part 58 GLP regulations and in compliance with FDA's Bioanalytical Method Validation Guidance...
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
Supplied From
Canada
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Contract Research Organisations (CROs) (Services)Laboratory and Analytical Equipment (Products)
All Categories
Analytical Chemistry (Biopharmaceutical Products)Analytical Methods (Biopharmaceutical Products)Analytical DevelopmentDevelopment & Validation of Analytical MethodsDrug DiscoveryProduct CharacterizationBio Analytical ServicesBioanalysisMonoclonal AntibodiesAntibody Drug Conjugates (ADCs)
